The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world induction targeted therapy (TT) with immune checkpoint inhibitor (ICI) therapy switch in BRAF-mutant metastatic melanoma.
 
Jane McKenzie
Honoraria - Astellas Oncology
 
Nadav Harel
No Relationships to Disclose
 
Sara Duarte Jardim Portela
No Relationships to Disclose
 
Kimberley Cao
No Relationships to Disclose
 
George Au-Yeung
Honoraria - Incyclix Bio
Consulting or Advisory Role - Incyclix Bio
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
 
Shahneen Sandhu
Honoraria - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Skyline Diagnostics (Inst)
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bristol Myers Squibb (Inst); Merck Sharp and Dohme (Inst); Novartis (Inst); Roche/Genentech (Inst); Skyline Diagnostics (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Endocyte/Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Senhwa Biosciences (Inst)
(OPTIONAL) Uncompensated Relationships - AAA/Endocyte/Novartis (Inst)
 
Lavinia Spain
Consulting or Advisory Role - Ipsen
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Iovance Biotherapeutics (Inst)